Marta Vismara

533 total citations
15 papers, 403 citations indexed

About

Marta Vismara is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marta Vismara has authored 15 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marta Vismara's work include Cancer Genomics and Diagnostics (9 papers), Cancer Cells and Metastasis (7 papers) and Cancer Diagnosis and Treatment (4 papers). Marta Vismara is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cancer Cells and Metastasis (7 papers) and Cancer Diagnosis and Treatment (4 papers). Marta Vismara collaborates with scholars based in Italy, United States and Germany. Marta Vismara's co-authors include Vera Cappelletti, Maria Grazia Daidone, Marco Silvestri, Simone Brivio, Mario Strazzabosco, Carolina Reduzzi, Marco Massani, Massimiliano Cadamuro, Luca Fabris and Tommaso Stecca and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.

In The Last Decade

Marta Vismara

15 papers receiving 400 citations

Peers

Marta Vismara

ONCOL

SURGE

PRM

Christian Vay Germany

Inge Ubink Netherlands

Binyi Xiao China

Valeria Pusceddu Italy

Guo‐He Lin China

Daiki Eguchi Japan

Priyamal Silva United Kingdom

Nicla Borrelli Italy

Adam G. Mace United States

Christian Vay Germany

Marta Vismara

314 ×1.1

ONCOL

202 ×1.0

205 ×1.4

62 ×0.6

SURGE

87 ×1.1

PRM

Citations per year, relative to Marta Vismara Marta Vismara (= 1×) peers Christian Vay

Countries citing papers authored by Marta Vismara

Since Specialization

Citations

This map shows the geographic impact of Marta Vismara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Vismara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Vismara more than expected).

Fields of papers citing papers by Marta Vismara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Vismara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Vismara. The network helps show where Marta Vismara may publish in the future.

Co-authorship network of co-authors of Marta Vismara

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Vismara. A scholar is included among the top collaborators of Marta Vismara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Vismara. Marta Vismara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Silvestri, Marco, Matteo Dugo, Marta Vismara, et al.. (2022). Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer. Scientific Reports. 12(1). 1470–1470. 14 indexed citations

Vismara, Marta, Carolina Reduzzi, Marco Silvestri, et al.. (2022). Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma. Clinical Chemistry. 68(5). 691–701. 13 indexed citations

Appierto, Valentina, Marco Silvestri, Rosalba Miceli, et al.. (2021). Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy. ESMO Open. 6(2). 100086–100086. 47 indexed citations

Silvestri, Marco, Carolina Reduzzi, Marta Vismara, et al.. (2021). Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers. 13(6). 1409–1409. 6 indexed citations

Reduzzi, Carolina, Serena Di Cosimo, Lorenzo Gerratana, et al.. (2021). Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer. Cancers. 13(10). 2356–2356. 36 indexed citations

Vismara, Marta, Carolina Reduzzi, Maria Grazia Daidone, & Vera Cappelletti. (2020). Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs. Advances in experimental medicine and biology. 1220. 81–91. 5 indexed citations

Cappelletti, Vera, Elena Verzoni, Raffaele Ratta, et al.. (2020). Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression. International Journal of Molecular Sciences. 21(4). 1475–1475. 27 indexed citations

Reduzzi, Carolina, Marta Vismara, Lorenzo Gerratana, et al.. (2019). The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells. Seminars in Cancer Biology. 60. 344–350. 32 indexed citations

Reduzzi, Carolina, Marta Vismara, Marco Silvestri, et al.. (2019). A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer. International Journal of Cancer. 146(12). 3495–3503. 24 indexed citations

10.

Reduzzi, Carolina, Marta Vismara, Marco Silvestri, et al.. (2019). A novel subpopulation of circulating tumor cells in patients with cholangiocarcinoma.. Journal of Clinical Oncology. 37(15_suppl). e15637–e15637. 1 indexed citations

11.

Cadamuro, Massimiliano, Simone Brivio, Joachim C. Mertens, et al.. (2018). Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. Journal of Hepatology. 70(4). 700–709. 144 indexed citations

12.

Cadamuro, Massimiliano, et al.. (2016). Mo1472 Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes Lymphangiogenesis in Cholangiocarcinoma. Gastroenterology. 150(4). S1124–S1124. 1 indexed citations

13.

Morton, Stuart, Massimiliano Cadamuro, Simone Brivio, et al.. (2015). Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation. Oncotarget. 6(28). 26052–26064. 49 indexed citations

14.

Cadamuro, Massimiliano, et al.. (2015). JNK signaling activated by Platelet-Derived Growth Factor D (PDGF-D) stimulates secretion of Vascular Endothelial Growth Factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastatization in cholangiocarcinoma. Digestive and Liver Disease. 47. e22–e23. 2 indexed citations

15.

Cadamuro, Massimiliano, et al.. (2015). P0220 : JNK signaling activated by platelet-derived growth factor D (PDGF-D) stimulates secretion of vascular endothelial growth factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastasization in cholangiocarcinoma. Journal of Hepatology. 62. S389–S389. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact